{"podcast":{"title":"Neurology Minute","slug":"neurology-minute-15117","podcast_index_feed_id":15117,"rss_url":"https://neurologyminute.libsyn.com/rss","website_url":"https://www.aan.com/education-and-research/online-learning-programs/podcasts/neurology-minute-podcast","image_url":"https://static.libsyn.com/p/assets/3/0/c/3/30c3c82925660375e55e3c100dce7605/NM_PodcastIcon_1400x1400.png","author":"Anna Rehbein","episode_count":1956,"summary":"The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.","last_synced_at":"2026-06-25T18:20:17.428469+00:00","page_url":"https://stenobird.com/podcast/neurology-minute-15117"},"episode":{"title":"Safety and Efficacy of Adjunct Dexamethasone in Adults with Herpes Simplex Virus Encephalitis in The UK - Part 3","slug":"safety-and-efficacy-of-adjunct-dexamethasone-in-adults-with-herpes-simplex-virus-encephalitis-in-the-uk-part-3","published_at":"2026-06-24T08:30:00+00:00","page_url":"https://stenobird.com/podcast/neurology-minute-15117/safety-and-efficacy-of-adjunct-dexamethasone-in-adults-with-herpes-simplex-virus-encephalitis-in-the-uk-part-3","show_page_url":"https://stenobird.com/podcast/neurology-minute-15117","url":"https://neurologyminute.libsyn.com/safety-and-efficacy-of-adjunct-dexamethasone-in-adults-with-herpes-simplex-virus-encephalitis-in-the-uk-part-3","audio_url":"https://traffic.libsyn.com/secure/neurologyminute/03_June_24th_2026_nm_v2.mp3?dest-id=1085030","summary":"In part three of this series, Dr. Aaron Zelikovich discusses the clinical outcomes seen during and after the acute infection and how these findings can guide physicians in counseling their patients. Show citation: Solomon T, Hooper C, Easton A, et al. Safety and efficacy of adjunct dexamethasone in adults with herpes simplex virus encephalitis in the UK (DexEnceph): a multicentre, observer-blind, randomised, phase 3, controlled trial. Lancet Neurol . 2026;25(2):136-146. doi: 10.1016/S1474-4422(25)00454-5","meta_description":"In part three of this series, Dr. Aaron Zelikovich discusses the clinical outcomes seen during and after the acute infection and how these findings can gu…","key_points":[],"chapters":[],"topics":[],"duration_seconds":158,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neurology-minute-15117/episodes/safety-and-efficacy-of-adjunct-dexamethasone-in-adults-with-herpes-simplex-virus-encephalitis-in-the-uk-part-3/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neurology-minute-15117/safety-and-efficacy-of-adjunct-dexamethasone-in-adults-with-herpes-simplex-virus-encephalitis-in-the-uk-part-3.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}